These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2440146)

  • 41. HLA-DR2, -DR5, and DRw6 associated Dw subtypes correlate with HLA-DR beta and -DQ beta restriction fragment length polymorphisms.
    Font MP; Gebuhrer L; Betuel H; Freidel C; Dausset J; Cohen D
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3361-5. PubMed ID: 3010292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphisms within the HLA-DRw6 haplotype. I. Restriction fragment length variation and its correlation with serology.
    Bosch ML; Schreuder GM; Spits H; Termijtelen A; Tilanus MG; Giphart MJ
    J Immunol; 1985 May; 134(5):3212-7. PubMed ID: 2984285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA analysis of histocompatibility antigens: fragments from the recently identified DR loci.
    Goldberg AC; Kalil J
    Braz J Med Biol Res; 1989; 22(7):849-57. PubMed ID: 2483529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular mapping of class II polymorphisms in the human major histocompatibility complex. I. DR beta.
    Bell JI; Denney D; MacMurray A; Foster L; Watling D; McDevitt HO
    J Immunol; 1987 Jul; 139(2):562-73. PubMed ID: 2885373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic HLA-typing by RFLP-analysis using DR beta and DQ beta cDNA probes reveals normal DR-DQ linkages in patients with psoriasis vulgaris.
    Olerup O; Wallin J; Carlsson B; Marcusson J; Emtestam L; Björnelius E; Möller E
    Tissue Antigens; 1987 Sep; 30(3):139-42. PubMed ID: 2892283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes.
    Petersdorf EW; Griffith RL; Erlich HA; Mickelson EM; Smith AG; Nisperos BB; Martin PJ; Hansen JA
    Immunogenetics; 1990; 32(2):96-103. PubMed ID: 1975801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of donor and recipient DRw6 status on outcome of cadaver kidney transplantation.
    Vereerstraeten P; Andrien M; Dupont E; De Pauw L; Kinnaert P; Toussaint C
    Transplant Proc; 1987 Feb; 19(1 Pt 1):708-10. PubMed ID: 3547836
    [No Abstract]   [Full Text] [Related]  

  • 48. DR beta-RFLP analysis of serologically DRw6 compatible kidney donor/recipient pairs.
    Endreffy E; Petri IB; Csajbók E; Márton J; Kaiser GI; Raskó I
    Haematologia (Budap); 1993; 25(2):143-8. PubMed ID: 7902315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells.
    Owerbach D; Lernmark A; Rask L; Peterson PA; Platz P; Svejgaard A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3758-61. PubMed ID: 6304735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An extended HLA-D region haplotype associated with celiac disease.
    Howell MD; Smith JR; Austin RK; Kelleher D; Nepom GT; Volk B; Kagnoff MF
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):222-6. PubMed ID: 2893373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restriction fragment length polymorphism in Felty's syndrome.
    Sansom DM; Bidwell JL; Klouda PT; Maddison PJ
    Dis Markers; 1986 Jun; 4(1-2):185-9. PubMed ID: 2898315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens.
    Bidwell J
    Immunol Today; 1988 Jan; 9(1):18-23. PubMed ID: 2908266
    [No Abstract]   [Full Text] [Related]  

  • 53. Mapping of a restriction fragment length polymorphism associated with defective DR beta 4 chain expression to the HLA-DRB1 gene.
    Sutton VR; Knowles RW
    Hum Immunol; 1988 Jun; 22(2):123-34. PubMed ID: 2901408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
    Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
    J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective PCR-RFLP method to distinguish HLA-DR1 from HLA-DR-"Br" (Dw Bon) alleles: applications in clinical histocompatibility testing.
    Bignon JD; Cesbron A; Cheneau ML; Bonneville F; Herry P; Muller JY
    Tissue Antigens; 1990 Oct; 36(4):171-3. PubMed ID: 1981816
    [No Abstract]   [Full Text] [Related]  

  • 56. Vaccine T-cell epitope selection by a peptide competition assay.
    Kilgus J; Romagnoli P; Guttinger M; Stuber D; Adorini L; Sinigaglia F
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1629-33. PubMed ID: 2466297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA-DR restriction-fragment-length polymorphisms in narcolepsy.
    Holloman JD; Bell JI; Kilduff TS; Dement WC; Guilleminault C; McDevitt HO
    J Neurosci Res; 1987; 18(1):239-44. PubMed ID: 2890770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Southern blot analysis of HLA class II beta genes in relation to HLA-D, DR specificities.
    Otani F; Okuda M; Kashiwagi N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):817-21. PubMed ID: 3824495
    [No Abstract]   [Full Text] [Related]  

  • 59. Restriction fragment polymorphism (RFLP) of a "new" HLA-DP specificity, CDP-HEI.
    Hyldig-Nielsen JJ; Odum N; Morling N; Svejgaard A
    Tissue Antigens; 1988 Mar; 31(3):161-3. PubMed ID: 2453937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of the HLA-DR profile of an HLA class II negative carcinoma cell line by restriction fragment length polymorphism (RFLP) analysis.
    Paulsen G; Markussen G; Sollid L; Thorsby E
    Tissue Antigens; 1987 Apr; 29(4):186-94. PubMed ID: 2887045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.